Literature DB >> 34041675

Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.

Cuiyu Jia1, Guangxue Liu2, Xinxin Wang3, Dawei Zhao4, Ruili Li5, Hongjun Li6.   

Abstract

PURPOSE: To investigate and compare the CT and MRI features of hepatic sclerosed hemangioma (HSH) and sclerosing cavernous hemangioma (SCH).
MATERIALS AND METHODS: Twelve HSH cases and 36 SCH cases were included, the imaging findings on CT (9 HSH and 34 SCH) and MRI (8 HSH and 10 SCH) were analyzed. Qualitative image analysis included the location, size, shape, capsular retraction, density, calcification, signal intensity on T1-weighted image (T1WI) and T2-weighted image (T2WI), presence of diffusion restriction, apparent diffusion coefficient (ADC) map, transient hepatic attenuation difference around the lesion, and the dynamic enhancement patterns.
RESULTS: The presence of liver cirrhosis in patients with HSH (3/12) was higher than SCH (1/36) (P = 0.043). The morphology appearance before enhancement showed no significant difference between HSH and SCH. Moreover, SCH had a stronger trend of centripetal enhancement patterns of cavernous hemangiomas (83.3%) compared to HSH (25%) (P < 0.001). Due to more frequent atypical enhancement features, containing rim-like enhancement, no enhancement, and peripheral heterogeneous enhancement, the misdiagnosis rate of HSH (75%) was significantly higher than that of SCH (16.7%) (P < 0.001). Furthermore, the ADC values of HSH and SCH were both higher than that of the surrounding liver parenchyma (P = 0.009, P = 0.002); however, there was no significant difference in ADC values between themselves (P = 0.613).
CONCLUSION: SCH showed the same trend of centripetal enhancement characteristics as typical hemangioma, while HSH exhibited atypical enhancement features due to complete sclerosis. Higher ADC values might contribute to the identification of atypical HSH and SCH from malignancies.

Entities:  

Keywords:  Computed tomography; Diagnosis; Hepatic sclerosed hemangioma; Magnetic resonance imaging; Sclerosing cavernous hemangioma

Year:  2021        PMID: 34041675     DOI: 10.1007/s11604-021-01139-z

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  33 in total

1.  Fading hepatic hemangiomas on multiphasic CT.

Authors:  Samira Alturkistany; Hyun-Jung Jang; Hojun Yu; Kyoung Ho Lee; Tae Kyoung Kim
Journal:  Abdom Imaging       Date:  2012-10

2.  Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography.

Authors:  Hyun-Jung Jang; Tae Kyoung Kim; Hyo Keun Lim; Sang Jae Park; Jung Suk Sim; Hyae Young Kim; Joo-Hyuk Lee
Journal:  AJR Am J Roentgenol       Date:  2003-01       Impact factor: 3.959

3.  A sclerosing hemangioma of the liver.

Authors:  Ji Soo Song; Yo Na Kim; Woo Sung Moon
Journal:  Clin Mol Hepatol       Date:  2013-12

4.  Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis.

Authors:  Hala R Makhlouf; Kamal G Ishak
Journal:  Liver       Date:  2002-02

5.  Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT.

Authors:  K W Kim; T K Kim; J K Han; A Y Kim; H J Lee; B I Choi
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

Review 6.  Hepatic haemangioma: common and uncommon imaging features.

Authors:  T Klotz; P-F Montoriol; D Da Ines; V Petitcolin; J Joubert-Zakeyh; J-M Garcier
Journal:  Diagn Interv Imaging       Date:  2013-06-21       Impact factor: 4.026

7.  Imaging of atypical hemangiomas of the liver with pathologic correlation.

Authors:  V Vilgrain; L Boulos; M P Vullierme; A Denys; B Terris; Y Menu
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

Review 8.  Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis.

Authors:  Filipe Caseiro-Alves; Jorge Brito; Antonio Eiras Araujo; Pedro Belo-Soares; Henrique Rodrigues; Augusta Cipriano; Daniel Sousa; Didier Mathieu
Journal:  Eur Radiol       Date:  2007-01-27       Impact factor: 5.315

9.  Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging.

Authors:  M G Jeong; J S Yu; K W Kim
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

Review 10.  Hepatic hemangioma -review-.

Authors:  N Bajenaru; V Balaban; F Săvulescu; I Campeanu; T Patrascu
Journal:  J Med Life       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.